C. Murray and A. Lopez, The Global Burden of Disease. A Comprehensive Assessment of Morbidity and Disability From Diseases, Injuries and Risk Factors in 1990 and Projected to 2020, 1996.
URL : https://hal.archives-ouvertes.fr/hal-00921564

P. Geoffroy, B. Etain, and J. Scott, Reconsideration of bipolar disorder as a developmental disorder: Importance of the time of onset, Journal of Physiology-Paris, vol.107, issue.4, pp.278-85, 2013.
DOI : 10.1016/j.jphysparis.2013.03.006

URL : https://hal.archives-ouvertes.fr/inserm-00811691

J. Scott and M. Leboyer, Consequences of delayed diagnosis of bipolar disorders, L'Enc??phale, vol.37, pp.173-175, 2011.
DOI : 10.1016/S0013-7006(11)70048-3

L. Yatham, S. Kennedy, and A. Schaffer, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009, Bipolar Disorders, vol.22, issue.Suppl. 1, pp.225-255, 2009.
DOI : 10.1111/j.1399-5618.2009.00672.x

H. Grunze, E. Vieta, and G. Goodwin, The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania, The World Journal of Biological Psychiatry, vol.161, issue.13, pp.85-116, 2009.
DOI : 10.4088/JCP.v69n0608

G. Goodwin, Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology, Journal of Psychopharmacology, vol.23, issue.4, pp.346-388, 2009.
DOI : 10.1177/0269881109102919

G. Malhi, D. Adams, and L. Lampe, Clinical practice recommendations for bipolar disorder, Acta Psychiatrica Scandinavica, vol.2, issue.s434, pp.27-46, 2009.
DOI : 10.1111/j.1600-0447.2009.01383.x

. American-psychiatric-association, Practice guideline for the treatment of patients with bipolar disorder (revision), Am J Psychiatry, vol.159, issue.4, pp.1-50, 2002.

H. Grunze, S. Kasper, and G. Goodwin, The World Federation of Socleties of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania, The World Journal of Biological Psychiatry, vol.10, issue.3, pp.5-13, 2003.
DOI : 10.1001/archpsyc.1979.01780050065007

H. Grunze, S. Kasper, and G. Goodwin, The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part III: Maintenance Treatment, The World Journal of Biological Psychiatry, vol.16, issue.3, pp.120-135, 2004.
DOI : 10.4088/JCP.v62n1011

G. Goodwin, Evidence-Based Guidelines for Treating Bipolar Disorder: Recommendations from the British Association for Psychopharmacology, Journal of Psychopharmacology, vol.17, issue.2, pp.149-173, 2003.
DOI : 10.1177/0269881103017002003

P. Llorca, P. Courtet, and P. Martin, D??pistage et prise en charge du trouble bipolaire : R??sultats, L'Enc??phale, vol.36, issue.4, pp.86-102, 2010.
DOI : 10.1016/S0013-7006(10)70037-3

L. Yatham, S. Kennedy, O. Donovan, and C. , Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies, Bipolar Disorders, vol.60, issue.Suppl. 3, pp.5-69, 2005.
DOI : 10.1111/j.1399-5618.2005.00219.x

F. Johnson, S. Ozdemir, and R. Manjunath, Factors That Affect Adherence to Bipolar Disorder Treatments, Medical Care, vol.45, issue.6, pp.545-552, 2007.
DOI : 10.1097/MLR.0b013e318040ad90

R. Perlis, M. Ostacher, and J. Patel, Predictors of Recurrence in Bipolar Disorder: Primary Outcomes From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), American Journal of Psychiatry, vol.163, issue.2, pp.217-224, 2006.
DOI : 10.1176/appi.ajp.163.2.217

C. Schneck, D. Miklowitz, and S. Miyahara, The Prospective Course of Rapid-Cycling Bipolar Disorder: Findings From the STEP-BD, American Journal of Psychiatry, vol.165, issue.3, pp.370-377, 2008.
DOI : 10.1176/appi.ajp.2007.05081484

R. Mcknight, M. Adida, and K. Budge, Lithium toxicity profile: a systematic review and meta-analysis, The Lancet, vol.379, issue.9817, pp.721-728, 2012.
DOI : 10.1016/S0140-6736(11)61516-X

T. Tomson and D. Battino, Teratogenic effects of antiepileptic drugs, The Lancet Neurology, vol.11, issue.9, pp.803-813, 2012.
DOI : 10.1016/S1474-4422(12)70103-5

M. Tohen, J. Goldberg, G. Arrillaga, and A. , A 12-Week, Double-blind Comparison of Olanzapine vs Haloperidol in the Treatment of Acute Mania, Archives of General Psychiatry, vol.60, issue.12, pp.1218-1226, 2003.
DOI : 10.1001/archpsyc.60.12.1218

P. Geoffroy, B. Etain, and C. Henry, Combination Therapy for Manic Phases: A Critical Review of a Common Practice, CNS Neuroscience & Therapeutics, vol.72, issue.Suppl. 5, pp.957-64, 2012.
DOI : 10.1111/cns.12017

URL : https://hal.archives-ouvertes.fr/inserm-00786653

A. Nivoli, A. Murru, and J. Goikolea, New treatment guidelines for acute bipolar mania: A critical review, Journal of Affective Disorders, vol.140, issue.2, pp.125-166, 2012.
DOI : 10.1016/j.jad.2011.10.015

P. Lim, S. Tunis, and W. Edell, Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines, Bipolar Disorders, vol.5, issue.1, pp.165-173, 2001.
DOI : 10.1001/archfami.4.2.135

M. Wolfsperger, W. Greil, and W. Rössler, Pharmacological treatment of acute mania in psychiatric in-patients between, J Affect Disord, vol.99, pp.1-39, 1994.

J. Haro, C. Reed, and A. Gonzalez-pinto, 2-year course of bipolar disorder type I patients in outpatient care: Factors associated with remission and functional recovery, European Neuropsychopharmacology, vol.21, issue.4, pp.287-293, 2011.
DOI : 10.1016/j.euroneuro.2010.08.001

J. Cookson, Use of antipsychotic drugs and lithium in mania, The British Journal of Psychiatry, vol.178, issue.41, pp.148-156, 2001.
DOI : 10.1192/bjp.178.41.s148

L. Smith, V. Cornelius, and A. Warnock, Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials, Bipolar Disorders, vol.66, issue.1, pp.551-560, 2007.
DOI : 10.1176/appi.ajp.160.9.1651

P. Garfinkel, H. Stancer, and E. Persad, A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania, Journal of Affective Disorders, vol.2, issue.4, pp.279-288, 1980.
DOI : 10.1016/0165-0327(80)90029-4

E. Klein, E. Bental, and B. Lerer, Carbamazepine and Haloperidol v Placebo and Haloperidol in Excited Psychoses, Archives of General Psychiatry, vol.41, issue.2, pp.165-170, 1984.
DOI : 10.1001/archpsyc.1984.01790130061009

A. Muller and K. Stoll, Carbamazepine and oxcarbazepine in the treatment of manic syndromes: studies in Germany, Traitement des phases Maniaques Anticonvulsants in Affective Disorders, pp.134-147

N. Desai, B. Gangadhar, and S. Channabasavanna, Carbamazepine hastens therapeutic action of lithium in mania, Proceedings Inter-national Conference on New Directions in Affective Disorders, p.97, 1987.

H. Möller, W. Kissling, T. Riehl, J. Bäuml, U. Binz et al., Doubleblind evaluation of the antimanic properties of carbamazepine as a comedication to haloperidol, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.13, issue.1-2, pp.127-136, 1989.
DOI : 10.1016/0278-5846(89)90009-2

A. Anand, . Oren, . Da, and R. Berman, Lamotrigine treatment of lithium failure outpatient mania: a double-blind, placebo-controlled trial, Abstract Book on 3rd international conference on Bipolar disorder, p.23, 1999.

B. Müller-oerlinghausen and A. Retzow, Valproate as an Adjunct to Neuroleptic Medication for the Treatment of Acute Episodes of Mania: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study, Journal of Clinical Psychopharmacology, vol.20, issue.2, pp.195-203, 2000.
DOI : 10.1097/00004714-200004000-00012

A. Pande, J. Crockatt, and C. Janney, Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy1, Bipolar Disorders, vol.2, issue.3.2, pp.249-255, 2000.
DOI : 10.1034/j.1399-5618.2000.20305.x

G. Sachs, F. Grossman, and S. Ghaemi, Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety, American Journal of Psychiatry, vol.159, issue.7, pp.1146-1154, 2002.
DOI : 10.1176/appi.ajp.159.7.1146

M. Tohen, K. Chengappa, and T. Suppes, Efficacy of Olanzapine in Combination With Valproate or Lithium in the Treatment of Mania in Patients Partially Nonresponsive to Valproate or Lithium Monotherapy, Archives of General Psychiatry, vol.59, issue.1, pp.62-69, 2002.
DOI : 10.1001/archpsyc.59.1.62

M. Delbello, M. Schwiers, and H. Rosenberg, A Double-Blind, Randomized, Placebo-Controlled Study of Quetiapine as Adjunctive Treatment for Adolescent Mania, Journal of the American Academy of Child & Adolescent Psychiatry, vol.41, issue.10, pp.1216-1223, 2002.
DOI : 10.1097/00004583-200210000-00011

L. Yatham, F. Grossman, and I. Augustyns, Mood stabilisers plus risperidone or placebo in the treatment of acute mania: International, double-blind, randomised controlled trial, The British Journal of Psychiatry, vol.182, issue.2, pp.141-147, 2003.
DOI : 10.1192/bjp.182.2.141

G. Sachs, K. Chengappa, and T. Suppes, Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study, Bipolar Disorders, vol.5, issue.1, pp.213-223, 2004.
DOI : 10.1001/jama.271.12.918

R. Mcintyre, J. Konarski, and M. Jones, Quetiapine in the treatment of acute bipolar mania: Efficacy across a broad range of symptoms, Journal of Affective Disorders, vol.100, issue.1, pp.5-14, 2007.
DOI : 10.1016/j.jad.2007.02.007

L. Yatham, E. Vieta, and A. Young, A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania, International Clinical Psychopharmacology, vol.22, issue.4, pp.212-220, 2007.
DOI : 10.1097/YIC.0b013e328080ca57

E. Vieta, T. 'joen, C. Mcquade, and R. , Efficacy of Adjunctive Aripiprazole to Either Valproate or Lithium in Bipolar Mania Patients Partially Nonresponsive to Valproate/Lithium Monotherapy: A Placebo-Controlled Study, American Journal of Psychiatry, vol.165, issue.10, pp.1316-1325, 2008.
DOI : 10.1176/appi.ajp.2008.07101560

M. Juruena, G. Ottoni, and R. Machado-vieira, Bipolar I and II disorder residual symptoms: Oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.33, issue.1, pp.94-99, 2009.
DOI : 10.1016/j.pnpbp.2008.10.012

A. Szegedi, J. Calabrese, and L. Stet, Asenapine as Adjunctive Treatment for Acute Mania Associated With Bipolar Disorder, Journal of Clinical Psychopharmacology, vol.32, issue.1, pp.46-55, 2012.
DOI : 10.1097/JCP.0b013e31823f872f

S. Akhondzadeh, M. Milajerdi, and H. Amini, Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial, Bipolar Disorders, vol.7, issue.1, pp.485-489, 2006.
DOI : 10.1034/j.1399-5618.2003.00041.x

N. Sussman, J. Mullen, and B. Paulsson, Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania, Journal of Affective Disorders, vol.100, issue.1, pp.55-63, 2007.
DOI : 10.1016/j.jad.2007.02.008

M. Tohen, C. Bowden, and A. Smulevich, Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes, The British Journal of Psychiatry, vol.192, issue.2, pp.135-143, 2008.
DOI : 10.1192/bjp.bp.107.041301

Z. Amrollahi, F. Rezaei, and B. Salehi, Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania, Journal of Affective Disorders, vol.129, issue.1-3, pp.1-3327, 2011.
DOI : 10.1016/j.jad.2010.08.015

J. Berwaerts, R. Lane, and I. Nuamah, Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: A randomized, placebo-controlled study, Journal of Affective Disorders, vol.129, issue.1-3, pp.1-3252, 2011.
DOI : 10.1016/j.jad.2010.09.011

W. Ouyang, M. Hsu, and I. Yeh, Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania, International Journal of Psychiatry in Clinical Practice, vol.133, issue.12, pp.178-88, 2012.
DOI : 10.1192/bjp.187.3.229

P. Geoffroy, B. Etain, and M. Leboyer, Une entit?? clinique aux implications th??rapeutiques majeures??: le trouble bipolaire ?? d??but pr??coce, Annales M??dico-psychologiques, revue psychiatrique, vol.170, issue.7, pp.502-509, 2012.
DOI : 10.1016/j.amp.2012.07.005

M. Bauer, K. Biswas, and A. Kilbourne, Enhancing Multiyear Guideline Concordance for Bipolar Disorder Through Collaborative Care, American Journal of Psychiatry, vol.166, issue.11, pp.1244-1250, 2009.
DOI : 10.1176/appi.ajp.2009.09030342